Informative Tools to Optimize Neoadjuvant Therapy in ER Positive, HER2 Negative Breast Cancers
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DIAGNOSTIC_TEST: Intervention 1|DIAGNOSTIC_TEST: Intervention 2
Sponsor: British Columbia Cancer Agency
Collaborators: Genomic Health®, Inc.